These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4790694)

  • 21. Anti-tumor activity in human serum: antibodies detecting blood-group-A-like antigen on the surface of tumor cells in culture.
    Bloom ET; Fahey JL; Peterson IA; Geering G; Bernhard M; Trempe G
    Int J Cancer; 1973 Jul; 12(1):21-31. PubMed ID: 4790705
    [No Abstract]   [Full Text] [Related]  

  • 22. Cellular immune reaction to human malignant melanoma and breast carcinoma cells.
    Canevari S; Fossati G; Della Porta G
    J Natl Cancer Inst; 1976 Apr; 56(4):705-9. PubMed ID: 1255793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular immunity against tumor-associated antigens in humans: lymphocyte stimulation and skin reaction.
    Vánky R; Klein E; Stjernswärd J; Nilsonne U
    Int J Cancer; 1974 Aug; 14(2):277-88. PubMed ID: 4376515
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells.
    Wybran J; Hellström I; Hellström KE; Fudenberg HH
    Int J Cancer; 1974 Apr; 13(4):515-21. PubMed ID: 4546321
    [No Abstract]   [Full Text] [Related]  

  • 25. Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects.
    Sulit HL; Golub SH; Irie RF; Gupta RK; Grooms GA; Morton DL
    Int J Cancer; 1976 Apr; 17(4):461-8. PubMed ID: 945229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 28. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of cell-mediated reactivity and serum blocking factors in melanoma patients on chemotherapy.
    Cummings FJ; Heppner GH; Calabresi P
    Med Pediatr Oncol; 1975; 1(3):195-206. PubMed ID: 1232528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,
    de Vries JE; Cornain S; Rumke P
    Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213
    [No Abstract]   [Full Text] [Related]  

  • 31. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
    Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
    J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Destruction of cultivated melanoma cells by lymphocytes from healthy Black (North American Negro) donors.
    Hellström I; Hellström KE; Sjögren HO; Warner GA
    Int J Cancer; 1973 Jan; 11(1):116-22. PubMed ID: 4790830
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
    Cohen AM; Ketcham AS; Morton DL
    J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
    [No Abstract]   [Full Text] [Related]  

  • 34. Lymphocytes with T-cell markers cooperate with IgG antibodies in the lysis of human tumour cells.
    Saal JG; Rieber EP; Hadam M; Riethmuller G
    Nature; 1977 Jan; 265(5590):158-60. PubMed ID: 299919
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.
    Baldwin RW; Embleton MJ; Price MR
    Int J Cancer; 1973 Jul; 12(1):84-92. PubMed ID: 4790711
    [No Abstract]   [Full Text] [Related]  

  • 36. Workshop in human tumor immunology.
    Oettgen HF; Bean MA; Klein G
    Cancer Res; 1972 Dec; 32(12):2845-53. PubMed ID: 4345410
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunologic reactions in malignant melanoma of the skin in man].
    Veresova OV; Korosteleva TA
    Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody-dependent cell-mediated cytotoxicity for human monolayer target cells bearing blood group and transplantation antigens and for melanoma cells.
    Kodera Y; Bean MA
    Int J Cancer; 1975 Oct; 16(4):579-92. PubMed ID: 1080751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.
    Ferrone S; Pellegrino MA
    J Natl Cancer Inst; 1977 May; 58(5):1201-4. PubMed ID: 67208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some aspects of the immune defense against cancer. II. In vitro studies on human tumors.
    Hellström I; Hellström KE
    Cancer; 1971 Nov; 28(5):1269-71. PubMed ID: 5125674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.